Literature DB >> 26989647

Castleman's disease of a submandibular mass diagnosed on Fine Needle Cytology: Report of a case with histopathological, immunocytochemical and imaging correlations.

Maria Gabriella Malzone1, Anna Cipolletta Campanile1, Veronica Sanna1, Franco Ionna2, Francesco Longo2, Annarosaria De Chiara1, Sergio Venanzio Setola3, Gerardo Botti1, Franco Fulciniti4.   

Abstract

Castleman's disease (CD) is an unusual inflammatory lymphoproliferative disorder of uncertain aetiology, mainly involving lymphatic tissue in the mediastinum, but also occurring in the neck, lung, abdomen, pelvis, skeletal muscle and retroperitoneum. Fine Needle Cytology (FNC) is a quick, cost-effective and safe diagnostic modality to investigate on organs involved by CD, also providing a guide to treatment and management of patients with lymphoadenopathy. We report a case of a 44-year-old man who underwent FNC of a submandibular mass with subsequent surgical excision. Cytology revealed an atypical lymphoproliferative process, which arose the suspicion of CD. Histopathological study of the excised masses combined with immunhistochemistry and imaging of the submandibular and neck areas, confirmed the suspicion. A final diagnosis of Unicentric Castleman's disease, hyaline-vascular type, was made.

Entities:  

Keywords:  Lymphoproliferative disorder; aspiration cytology; hyaline vascular type

Year:  2016        PMID: 26989647      PMCID: PMC4761582          DOI: 10.5582/irdr.2016.01006

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN: 2186-3644


  38 in total

1.  Fine-needle aspiration findings in Castleman's disease.

Authors:  L Meyer; D Gibbons; R Ashfaq; F Vuitch; M H Saboorian
Journal:  Diagn Cytopathol       Date:  1999-07       Impact factor: 1.582

Review 2.  The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care.

Authors:  Corey Casper
Journal:  Br J Haematol       Date:  2005-04       Impact factor: 6.998

3.  Castleman disease of the parotid gland in childhood: an unusual entity.

Authors:  Jae Hong Park; Seung Won Lee; Yoon Woo Koh
Journal:  Auris Nasus Larynx       Date:  2007-11-08       Impact factor: 1.863

4.  Fine-needle aspiration in the management of peripheral lymphadenopathy in a developing country.

Authors:  J O Thomas; D Adeyi; H Amanguno
Journal:  Diagn Cytopathol       Date:  1999-09       Impact factor: 1.582

5.  Parotid Castleman's disease.

Authors:  J Panayiotides; T Tsilalis; N Bollas; A Karameris
Journal:  Cytopathology       Date:  1998-02       Impact factor: 2.073

Review 6.  The use of fine needle aspiration biopsy in the evaluation of lymphadenopathy.

Authors:  M H Saboorian; R Ashfaq
Journal:  Semin Diagn Pathol       Date:  2001-05       Impact factor: 3.464

7.  Castleman's disease: A rare lymphoproliferative disorder.

Authors:  T E F Jongsma; R J Verburg; P H L M Geelhoed-Duijvestijn
Journal:  Eur J Intern Med       Date:  2007-03       Impact factor: 4.487

Review 8.  Benign non-infectious causes of lymphadenopathy: A review of cytomorphology and differential diagnosis.

Authors:  Sara E Monaco; Walid E Khalbuss; Liron Pantanowitz
Journal:  Diagn Cytopathol       Date:  2012-02-20       Impact factor: 1.582

Review 9.  Neoadjuvant radiotherapy of primary irresectable unicentric Castleman's disease: a case report and review of the literature.

Authors:  Iris A C de Vries; Marjolein M S van Acht; Thomas B J Demeyere; Marnix L M Lybeert; Jean-Paul de Zoete; Grard A P Nieuwenhuijzen
Journal:  Radiat Oncol       Date:  2010-02-02       Impact factor: 3.481

10.  Expression of interleukin-6 in Castleman's disease.

Authors:  S M Hsu; J A Waldron; S S Xie; B Barlogie
Journal:  Hum Pathol       Date:  1993-08       Impact factor: 3.466

View more
  1 in total

Review 1.  A Cytological Review of Follicular Dendritic Cell-Derived Tumors with Emphasis on Follicular Dendritic Cell Sarcoma and Unicentric Castleman Disease.

Authors:  José A Jiménez-Heffernan; Cristina Díaz Del Arco; Magdalena Adrados
Journal:  Diagnostics (Basel)       Date:  2022-02-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.